|

Ezetimibe 10mg + Rosuvastatin 5mg Clinical Trials

1 actively recruiting trial

Also known as: Rosuzet 10/5 mg

Pipeline

Phase 4: 1

Top Sponsors

  • Kiyuk Chang, MD,PhD1

Indications

  • HMG-CoA Reductase Inhibitor Toxicity1
  • Statin Adverse Reaction1
  • Myocardial Infarction1
  • Heart Disease1

Other1 trial

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.